Results 31 to 40 of about 1,057,698 (355)

Spring Semester 2009 [PDF]

open access: yes, 2009
A short-run newsletter published by the Student Athlete Advisory Committee of Providence College. (Spring Semester 2009 - 4 pages in total.

core   +1 more source

PARP inhibitors elicit distinct transcriptional programs in homologous recombination competent castration‐resistant prostate cancer

open access: yesMolecular Oncology, EarlyView.
PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham   +21 more
wiley   +1 more source

Transaction costs for collaboration in the watershed management of the Cuyahoga River Area of Concern

open access: yesRegional Sustainability, 2022
This study examines the transaction costs of collaborative watershed management in the Cuyahoga River Area of Concern (AOC)—one of the 43 geographic areas designated by the U.S.
Scott Daniel Hardy
doaj   +1 more source

Mersey & Weaver Fisheries Advisory Committee 21st April, 1975 [PDF]

open access: yes, 1975
This is the report from the Mersey and Weaver Fisheries Advisory Committee meeting, which was held on the 21st April, 1975. It covers information on fishery byelaws, and a report by Unit Water Quality Officer on fisheries activities.

core  

Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology

open access: yesMolecular Oncology, EarlyView.
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts   +8 more
wiley   +1 more source

Eden Fisheries Advisory Committee 29th April, 1975 [PDF]

open access: yes, 1975
This is the report from the Eden Fisheries Advisory Committee meeting, which was held on the 29th April, 1975. It covers information on fishery byelaws, and a report by unit fisheries officer on fisheries activities.

core  

The influence of ROS1 fusion partners and resistance mechanisms in ROS1‐TKI‐treated non‐small cell lung cancer patients

open access: yesMolecular Oncology, EarlyView.
This real‐world study of ROS1+ NSCLC highlights fusion diversity, treatment outcomes with crizotinib and lorlatinib, and in vitro experiments with resistance mechanisms. G2032R drives strong resistance to ROS1‐targeted TKIs, especially lorlatinib. Fusion partner location does not affect overall survival to crizotinib or lorlatinib. Findings support the
Fenneke Zwierenga   +8 more
wiley   +1 more source

Consensus Statement by the Expert Advisory Committee

open access: yesКардиоваскулярная терапия и профилактика, 2012
Тема: Место комбинированной гиполипидемической терапии (статин + эзетимиб) в лечении дислипидемий Дата: 09.10.2011 Место проведения: г. Москва Председатели: Президент ВНОК, акад. РАМН Р.Г.
article Editorial
doaj   +1 more source

Regional Fisheries Advisory Committee 3rd November 1975. [PDF]

open access: yes, 1975
This is the report from the Regional Fisheries Advisory Committee meeting, which was held on the 3rd November 1975. The report contains information on the proceedings of the Local Fisheries Advisory Committee and recommendations for these committees ...

core  

Gut microbiota diversity is prognostic in metastatic hormone receptor‐positive breast cancer patients receiving chemotherapy and immunotherapy

open access: yesMolecular Oncology, EarlyView.
In this exploratory study, we investigated the relationship between the gut microbiota and outcome in patients with metastatic hormone receptor‐positive breast cancer, treated in a randomized clinical trial with chemotherapy alone or chemotherapy in combination with immune checkpoint blockade.
Andreas Ullern   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy